Evidence map›Paper›PMID 31222455›Full record

ArticleClinical journal of gastroenterology2020

Two cases of bile duct carcinoma patients who underwent the photodynamic therapy using talaporfin sodium (Laserphyrin

Atsushi Nanashima, Masahide Hiyoshi, Naoya Imamura, Takeomi Hamada, Takahiro Nishida, Hiroshi Kawakami, Tesshin Ban, Yoshimasa Kubota, Koji Nakashima, Koichi Yano and 3 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Atsushi NanashimaDivision of Hepato-Biliary-Pancreas Surgery, Department of Surgery, University of Miyazaki Faculty of Medicine, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan. a_nanashima@med.miyazaki-u.ac.jp.
Masahide HiyoshiDivision of Hepato-Biliary-Pancreas Surgery, Department of Surgery, University of Miyazaki Faculty of Medicine, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Naoya ImamuraDivision of Hepato-Biliary-Pancreas Surgery, Department of Surgery, University of Miyazaki Faculty of Medicine, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Takeomi HamadaDivision of Hepato-Biliary-Pancreas Surgery, Department of Surgery, University of Miyazaki Faculty of Medicine, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Takahiro NishidaDivision of Gastrointestinal, Endocrine and Pediatric Surgery, Department of Surgery, University of Miyazaki Faculty of Medicine, Miyazaki, Japan.
Hiroshi KawakamiDivision of Gastroenterology and Hepatology, Department of Internal Medicine, University of Miyazaki Faculty of Medicine, Miyazaki, Japan.
Tesshin BanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, University of Miyazaki Faculty of Medicine, Miyazaki, Japan.
Yoshimasa KubotaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, University of Miyazaki Faculty of Medicine, Miyazaki, Japan.
Koji NakashimaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, University of Miyazaki Faculty of Medicine, Miyazaki, Japan.
Koichi YanoDivision of Hepato-Biliary-Pancreas Surgery, Department of Surgery, University of Miyazaki Faculty of Medicine, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Takashi WadaDivision of Hepato-Biliary-Pancreas Surgery, Department of Surgery, University of Miyazaki Faculty of Medicine, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Shinsuke TakenoDivision of Gastrointestinal, Endocrine and Pediatric Surgery, Department of Surgery, University of Miyazaki Faculty of Medicine, Miyazaki, Japan.
Masahiro KaiDepartment of Surgery, Miyazaki Medical Association Hospital, Miyazaki, Japan.
University of Miyazaki · JP

Funding

JSGE JSGE2019
6 · The paper itself

Abstract

The efficacy of adjuvant photodynamic therapy (PDT) using the new photosensitizer, talaporfin sodium (TPS) has been clinically examined in some patients with bile duct carcinoma (BDC). Based on our previous cohorts, a prospective clinical trial was attempted; however, only two cases were ultimately enrolled in 27 months. A 664-nm semiconductor laser (100 J/cm

Indexed as

AgedAged, 80 and overBile Duct NeoplasmsCarcinomaFemaleHumansLow-Level Light TherapyPhotochemotherapyPhotosensitizing AgentsPorphyrinsPhotosensitizing AgentsPorphyrinsTalaporfinAdvanced bile duct carcinomaPhotodynamic therapySemiconductor laserTalaporfin sodium

Identifiers

PMID31222455
OpenAlexW2951531328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.